Janux Therapeutics Inc (JANX): Eigentümerstruktur
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Janux Therapeutics Inc
Mitarbeiter 113
Handelsplatz NASDAQ
Ticker Symbol JANX
IPO Datum 2021-06-11
Adresse 10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130
Webseite https://www.januxrx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. David Alan Campbell Ph.D. | President, Co-Founder, CEO & Director |
| 2 | Dr. Thomas Diraimondo Ph.D. | Chief Scientific Officer |
| 3 | Ms. Janeen Doyle | Chief Corporate & Business Development Officer |
| 4 | Mr. Matt Whitmire | Vice President of Finance |
| 5 | Ms. Maria Dobek | Vice President of Accounting |
| 6 | Mr. Charles M. Winter | Chief Technical Officer |
| 7 | Mr. James Pennington | General Counsel & Corporate Secretary |
| 8 | Ms. Mandie Forman-Sklansky | Head of Human Resources |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RA Capital Management, LLC | 18,30% | 0,19 Mrd. USD |
| 2 | BlackRock Inc | 8,89% | 0,09 Mrd. USD |
| 3 | HHG PLC | 6,86% | 0,07 Mrd. USD |
| 4 | Prosight Management, LP | 6,22% | 0,07 Mrd. USD |
| 5 | FMR Inc | 4,15% | 0,04 Mrd. USD |
| 6 | State Street Corp | 4,03% | 0,04 Mrd. USD |
| 7 | Federated Hermes Inc | 3,85% | 0,04 Mrd. USD |
| 8 | Vanguard Capital Management, LLC | 2,96% | 0,03 Mrd. USD |
| 9 | TCG Crossover Management, LLC | 2,93% | 0,03 Mrd. USD |
| 10 | Alyeska Investment Group, L.P. | 2,62% | 0,03 Mrd. USD |
| 11 | Wellington Management Company LLP | 2,47% | 0,03 Mrd. USD |
| 12 | Vanguard Portfolio Management, LLC | 2,11% | 0,02 Mrd. USD |
| 13 | Two Sigma Investments LLC | 1,97% | 0,02 Mrd. USD |
| 14 | Citadel Advisors Llc | 1,96% | 0,02 Mrd. USD |
| 15 | Point72 Asset Management, L.P. | 1,89% | 0,02 Mrd. USD |
| 16 | Geode Capital Management, LLC | 1,88% | 0,02 Mrd. USD |
| 17 | Algert Global LLC | 1,82% | 0,02 Mrd. USD |
| 18 | D. E. Shaw & Co LP | 1,79% | 0,02 Mrd. USD |
| 19 | Balyasny Asset Management LLC | 1,78% | 0,02 Mrd. USD |
| 20 | Orbimed Advisors LLC | 1,61% | 0,02 Mrd. USD |